Newsroom

Industry News

26 Jul

BioLineRx Announces Additional Investment From BVF Partners L.P.

TEL AVIV, Israel, July 26, 2017 /PRNewswire/ — BioLineRx Ltd. (BLRX) (BLRX.TA), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that BVF Partners L.P. (BVF), its largest shareholder, has entered into a definitive agreement to make an additional, direct investment of $9.6 million in BioLineRx, increasing its economic interest in...

Read more

25 Jul

Onconova Therapeutics Announces Establishment of Collaborative Research and Clinical Programs Evaluating Rigosertib in Pediatric “RASopathies”

Company to highlight approaches for studying rigosertib in multiple rare diseases associated with RAS gene at upcoming scientific conference Collaboration with National Cancer Institute (NCI) for evaluation of rigosertib in pediatric rare disease Onconova to host KOL breakfast symposium for investors on October 11th, 2017 NEWTOWN, Pa., July 25,...

Read more

25 Jul

Youngevity International Adds Luke Taffuri as VP of International Sales and Operations

SAN DIEGO, CA–(Marketwired – Jul 25, 2017) – Youngevity International, Inc. ( NASDAQ :YGYI ), a leading omni-direct lifestyle company, today announced the appointment of Luke Taffuri to its management team as VP of International Sales and Operations. Mr. Taffuri brings more than 22 years of Direct Selling experience in various positions including Chief...

Read more

25 Jul

Abeona Therapeutics Announces Appointment of Juan Ruiz as Chief Medical Officer

NEW YORK and CLEVELAND, July 25, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, announced today that Juan Ruiz, M.D., Ph.D., MBA has joined the company as Chief Medical Officer. He will be responsible...

Read more

25 Jul

Moleculin’s New Drug for the Treatment of Glioblastoma Nears Clinical Trials at MD Anderson Cancer Center

HOUSTON, TX–(Marketwired – July 25, 2017) – Moleculin Biotech, Inc., (MBRX)(“Moleculin” or the “Company”), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced it...

Read more

25 Jul

Ascent Solar Delivers First Shipment of A Major Contract to Supply High-Voltage Superlight Thin-Film Modules for High Altitude Aerospace Application

THORNTON, CO–(Marketwired – Jul 25, 2017) – Ascent Solar Technologies, Inc. (OTCQB : ASTI ), a developer and manufacturer of state-of-the-art, lightweight, and flexible thin-film photovoltaic (PV) solutions, announces that the Company has successfully delivered the first shipment of the major contract on June 26, 2017 pursuant to announcement made on January...

Read more

24 Jul

ProBility Media Corp. Further Expands International Educational and Training Product Offerings with Purchase of Cranbury International

HOUSTON, TX–(Marketwired – Jul 24, 2017) –  ProBility Media Corp. (OTCQB: PBYA), an EdTech company building the first full-service training and career advancement brand for the skilled trades, today announced that it has signed a binding letter of intent to purchase Cranbury International, an exporter of educational and reference materials,...

Read more

Page 30 of 274« First...1020...2829303132...405060...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address